Studies of lysozyme have played a major role over several decades in defining the general principles underlying protein structure, folding, and stability. Following the discovery some 10 years ago that two mutational variants of lysozyme are associated with systemic amyloidosis, these studies have been extended to investigate the mechanism of amyloid fibril formation. This Account describes our present knowledge of lysozyme folding and misfolding, and how the latter can give rise to amyloid disease. It also discusses the significance of these studies for our general understanding of normal and aberrant protein folding in the context of human health and disease.
Introduction
Since its discovery by Alexander Fleming in 1922, human lysozyme has been a rich source of information on many fundamental aspects of protein science. Moreover, in the early 1990s, it was found that two lysozyme variants (I56T and D67H) are associated with a form of hereditary nonneuropathic systemic amyloidosis in which amyloid fibrils containing the full-length variant proteins are deposited in various organs 1 [ Figure 1 ]. More recently, other naturally occurring amyloidogenic variants (F57I, F57I/T70N, W64R, and T70N/W112R) [2] [3] [4] and one nonamyloidogenic variant (T70N) 5 have been reported. The depth of knowledge that has accumulated on wild-type lysozyme (for reviews see refs 6 and 7) has enabled detailed studies of the effects of these mutations on the properties of the protein including its folding, stability, and aggregation behavior. In this Account, we summarize the results of these studies and describe how they provide molecular insights into both the mechanism by which lysozyme converts in vitro into its fibrillar state and the origin of the amyloid disorder with which this process is associated in vivo. In addition, we discuss the significance of the study of lysozyme for understanding the more general issues of protein misfolding and the nature of protein deposition diseases. Finally, we show how the results of these studies give rise to new insights into the structures of proteins and the evolutionary pressures that have resulted in their remarkable and varied characteristics.
Folding and Unfolding of Human Lysozyme
Wild-type human lysozyme is a 14 kDa enzyme, whose native structure consists of two closely interacting structural regions called the R-domain and the -domain, and is cross-linked by four disulfide bonds, one of which (77-95) links the two domains [ Figure 2 ]. All natural mutations discovered so far are located in the -domain with the exception of the W112R mutation, which is in the D helix of the R-domain [ Figure 2 ]; this latter mutation has, however, only been found in conjunction with the -domain mutation T70N. X-ray crystallographic data have shown that the I56T, D67H, and T70N variants have the same overall native fold as the wild-type protein with all disulfide bonds correctly formed. 8, 9 These variants are functional, with specific activities very similar to that of the wild-type protein. 8, 10 Folding from the Reduced State. Because lysozyme is an extracellular protein, its folding in vivo takes place in the oxidizing environment of the lumen of the endoplasmic reticulum prior to secretion via the Golgi apparatus. The refolding of the wild-type, I56T, and D67H lysozymes from their reduced states in guanidinium chloride (where the protein is highly denatured and with all eight cysteine residues in the free thiol form) has therefore been studied in vitro under oxidative conditions designed to mimic, at least in general terms, protein folding in the endoplasmic reticulum.
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Under these conditions, the reduced proteins all correspond to ensembles of unfolded conformers, and in the initial stages of folding these species collapse rapidly via a large number of parallel pathways to form a multitude of relatively unstructured intermediates having one or two disulfide bonds. The majority of these species then fold to form a native-like three-disulfide intermediate lacking the (77-95) bond. The final and slowest step involves a conformational rearrangement requiring at least local unfolding of these latter species in order to allow the remaining free thiol groups to form the fourth disulfide linkage and hence to generate the fully oxidized native protein. Although, the I56T and D67H variants refold in a manner qualitatively similar to that of wild-type lysozyme, an interesting and initially unexpected finding is that they fold faster by a factor of 2 and 3, respectively. 11 The origin of this observation, however, can be attributed primarily to the fact that the lower stabilities of the native-like intermediates of the variants compared with those of the wild-type protein facilitate the conformational rearrangements associated with the final folding step.
Folding in the Presence of Disulfide Bonds. The efficient in vitro oxidative folding of the variant proteins is consistent with the finding that ex vivo lysozyme fibrils are composed only of full-length variant proteins containing all native disulfide bonds. 1, 8 Moreover, because these pathological fibrillar deposits are predominantly extracellular, it is likely that the amyloidogenic variants are not only synthesized but also secreted correctly in significant quantities; the folding and unfolding processes underlying their later conversion into amyloid fibrils will therefore in all probability involve only species in which all four disulfide bonds are correctly formed. We and others have studied these processes in vitro in detail for wild-type lysozyme and some of its natural variants. These studies have been described extensively in previous review articles, 6 ,7 and we shall therefore simply summarize here the most important findings.
The unfolding kinetics of the I56T, D67H, and T70N variants and wild-type lysozyme in high concentrations of guanidinium chloride have all been found to fit well to single-exponential functions. However, the T70N, I56T, and D67H variants unfold, respectively, about 3, 30, and 160 times faster than wild-type lysozyme. 10, 12 The refolding of wild-type lysozyme from its guanidinium chloride denatured state occurs via multiple parallel tracks and through a series of well-defined metastable intermediates that become progressively structured in discrete domains. The majority of the protein molecules follow a slow track, the first step of which involves the stabilization of the A and B helices and the C-terminal 3 10 helix in a locally cooperative manner. 12, 13 This step is followed by the cooperative folding of helices C and D leading to an intermediate in which the R-domain has a native-like structure and then by the folding of the -domain. As found for the homologous hen egg-white lysozyme, it is likely that a final step involving the docking of the two domains is required to generate the native close-packed structure with a functional active site. 6, 7 About 10% of the Normal and Aberrant Biological Self-Assembly Dumoulin et al.
molecules, however, fold along a fast track in which the native state is formed more efficiently than it is for the majority of molecules, because the -domain becomes structured concomitantly with the R-domain. These observations are similar to those obtained for the folding of hen lysozyme and the homologous R-lactalbumins [ Figure  3 ]. All of these studies have contributed to the development of a "new view" of protein folding in terms of a stochastic search process on a highly evolved energy landscape determined by the protein sequence 14, 15 [ Figure  3 ].
The refolding of both the I56T and D67H variants also occurs via multiple parallel pathways and through a series of well-defined intermediates. The refolding of the D67H variant is virtually identical to that of the wild-type protein, whereas for the I56T variant, the coalescence of the -domain onto the folded R-domain is about 10 times slower. 12 These findings can be attributed to the fact that residue 67 is located in a loop region within the -domain, while residue 56 is located at the crucial interface between the R and domains.
Misfolding and Aggregation of Human Lysozyme
Reduced Stability and Cooperativity of the Amyloidogenic Variants. The thermostability of all four single-point amyloidogenic variants (I56T, F57I, W64R, and D67H) is remarkably decreased by almost exactly the same amount (12 ( 2°C at pH 5.0) relative to the wild-type protein; 8, 16, 17 by contrast, the nonamyloidogenic T70N variant is only marginally destabilized (by ∼4°C).
9,10 Moreover, not only do the amyloidogenic mutations drastically reduce the stability of the protein, but they also significantly reduce the cooperativity of the thermal unfolding process. 8, [16] [17] [18] Most importantly, the global cooperativity of the amyloidogenic variants is substantially reduced at equilibrium under physiologically relevant conditions; 16, 19 hydrogen/ deuterium exchange experiments monitored by mass spectrometry and NMR spectroscopy have clearly demonstrated that at pH 5-8 and 35-37°C, both the I56T and D67H variants populate transiently a partially unfolded species [ Figure 5a ]. In this intermediate species, which is remarkably similar for both variants despite the different locations of the mutations, the regions of the protein that form the -domain and the adjacent C-helix in the native state are simultaneously unfolded, whereas the regions forming the remainder of the R-domain maintain their native-like structure [ Figure 5f ]. 16, 19 This partial and transient unfolding event is not detectable in vitro for the nonamyloidogenic T70N variant or for the wild-type protein under physiologically relevant conditions; it is, however, detectable for these two proteins under more destabilizing conditions. 9 Taken together, these results suggest that T70N lysozyme is not sufficiently destabilized to allow population of the amyloidogenic intermediate under physiological conditions at a level that results in pathogenic aggregation. This conclusion rationalizes the fact that the T70N mutation has not been found to form amyloid fibrils in people carrying this mutation and suggests that there may be only a relatively narrow window of stability that results in pathogenic behavior. In accord with this conclusion, although patients suffering from lysozyme amyloidosis are all heterozygotes, the deposits appear to be composed exclusively of the amyloidogenic variants. 1, 8 To begin to explore further the link between stability and amyloid disease, we have investigated the levels of secretion of a range of mutational variants of lysozyme in Pichia pastoris into which the lysozyme gene has been inserted. 17 In this eukaryotic organism, we have observed a strong correlation between the thermostability of each variant and its secretion level, presumably because the latter reflects a lower probability of satisfying the quality FIGURE 3. A schematic free-energy (F) surface illustrating the folding of hen lysozyme. Q R and Q represent the number of native contacts present in the R-domain and -domain, respectively, at different stages of folding. Protein molecules are initially in a denatured ensemble and two trajectories are illustrated by which they can achieve the native fold. One represents a "fast track" (yellow trajectory) and shows a lysozyme molecule in which nativelike structure in the two domains forms concurrently and the molecule populates an intermediate state (B) briefly prior to achieving the native state (C). Another lysozyme molecule is illustrated following a "slow track" (cyan trajectory) in which the polypeptide chain becomes temporarily trapped in an intermediate state (A), which contains persistent structure in the R-domain but not the -domain; further folding of this intermediate involves either a transition over a higher barrier or partial unfolding to enable the remainder of the folding process to occur along the fast track. The ensembles of structures shown for the intermediate states (A and B) are based on restrained molecular dynamics simulations using experimental data from studies of human R-lactalbumin, a protein homologous to hen lysozyme and for which stable intermediates can be generated and studied in detail. 36 control mechanisms within the cell for protein of reduced stability. As far as amyloid disease is concerned, a lower level of protein secretion will, at least in the absence of other factors, reduce the probability of aggregation in the extracellular environment, but the reduced stability of the native state will increase the probability of aggregation. A complex interplay between reduced stability, lower secretion levels, and intrinsic aggregation propensity is therefore likely to determine the types of mutation that give rise to familial forms of amyloid disease.
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Links between Normal Folding and Amyloid Formation. The I56T, D67H, and T70N variants, and indeed wildtype human lysozyme, are all able to form amyloid fibrils in vitro when they are incubated under conditions where a significant fraction of the protein molecules are at least partially unfolded, such as low pH, high temperature, or moderate concentrations of denaturant. 6, 7 However, as a result of their lower stability and cooperativity, and therefore their higher ability to populate partially unfolded states, the amyloidogenic variants form fibrils in vitro much more easily than the T70N variant and especially than the wild-type protein. 9, 18 Fibrils formed in vitro from the various lysozyme species studied in this way do, however, resemble those formed in vivo, and their amyloid character has been shown by a wide variety of techniques, 6 ,7 some of which are illustrated in Figure 4 . The kinetics of in vitro aggregation are sigmoidal, showing a lag phase followed by exponential growth [ Figure 4a ]. Moreover, fibril formation by I56T, D67H, and wild-type lysozymes are greatly accelerated by seeding with preformed fibrils formed from either a variant or the wildtype protein. 18 These results are all consistent with a nucleation-dependent growth process that increasingly appears to be a common feature of fibril formation. 6, 7 One of the most striking features of the transiently populated intermediates characterized for the amyloidogenic I56T and D67H variants under physiologically relevant conditions is that they have marked similarities not just to each other but also to the dominant R-domain intermediate detected during their nonoxidative folding. This observation can be rationalized on the basis of structural data which suggest that, for both variants, mutations destabilize the interface between the R-and -domains. Indeed, perturbation of this region is likely to be the key factor in the reduction of the cooperativity between the two domains of the native proteins and of the stability of the -domain and the C-helix, which are linked via the 77-95 disulfide bond. 8 As a substantial part of the region destabilized by the mutations forms -sheet structure in the native protein, the initial steps in the aggregation process could simply involve the formation of intermolecular interactions such as hydrogen bonds in the region of the protein that is transiently exposed in the intermediate, rather than the intramolecular interactions characteristic of the native structure [ Figure 5c ]. These observations suggest that the processes of protein folding and aggregation are closely coupled and underline the need to study both processes in detail to understand properly how they occur and how they are connected to each other.
When the structurally homologous hen lysozyme is incubated at low pH and elevated temperatures, peptide fragments corresponding to parts of the -domain and to all of the C-helix are readily cleaved from the protein. 20 Remarkably, these fragments correspond almost exactly to the regions of the I56T and D67H human variants that unfold to form the intermediates discussed above. In addition, these fragments have been found to form amyloid fibrils rapidly after purification; by contrast, the fragments corresponding to the rest of the protein remain predominantly soluble under the same conditions. This result indicates that the region of lysozyme corresponding to the -domain and the C-helix not only can unfold with local cooperativity but also has a higher intrinsic propensity to aggregate than other regions of the protein. Interestingly, a similar result is predicted for human lysozyme by analyzing its sequence with an algorithm developed to rationalize the relative aggregation propensities of different polypeptides. 21 The highly amyloidogenic character of this region is probably the reason all but one of the known amyloidogenic mutations are localized in the -domain. The fact that the single R-domain mutation, W112R, has only been found in conjunction with the -domain mutation T70N 4 suggests that this substitution results in additional destabilization of the T70N variant enabling it to form pathogenic aggregates in vivo.
Inhibition of Amyloid Formation. The detail in which the processes of lysozyme folding and amyloid formation are understood provides an important opportunity to design strategies to inhibit the conversion of the variants Normal and Aberrant Biological Self-Assembly Dumoulin et al. into amyloid fibrils. In light of the conclusion that the lower stability and cooperativity of the amyloidogenic variants is likely to be a primary factor in their enhanced amyloidogenicity, we have explored the possibility of stabilizing these proteins through binding to another molecule. To test this strategy, we have investigated the effects of binding a heavy-chain camelid antibody fragment raised against wild-type human lysozyme and referred to as cAb-HuL6. 22 These experiments reveal that the specific binding of cAb-HuL6 reverses the loss of global structural cooperativity that results from the mutations; that is, in the presence of an equimolar quantity of the antibody fragment virtually none of the molecules of the I56T and D67H proteins undergoes even a single unfolding event of the type observed for the lysozyme variants when unbound. The result of this binding is to prevent the ready in vitro conversion of the lysozyme variants into their aggregated states [ Figure 5b,d ,e]. 16, 23 Structural studies of the complex between wild-type human lysozyme and cAb-HuL6 have revealed that the epitope on the lysozyme molecule includes neither the sites of the mutations nor most of the residues in the region of the structure that is destabilized by the mutations 23 [ Figure 5f ]. Thus, the effects of binding are not simply to mask this latter region and prevent its unfolding from the remainder of the structure. Rather, it appears that the binding of cAb-HuL6 acts by restoring the global cooperativity of the native structure via, at least in part, the transmission of small but significant long-range conformational effects through the protein to the interface between the two structural domains. These results demonstrate the close link between the reduction of global cooperativity in the amyloidogenic variants, and hence their increased tendency to populate a partially unfolded intermediate state and their propensity to convert into amyloid fibrils. These conclusions therefore reinforce the view that the cooperativity of native protein structures is an essential evolutionary development to enable otherwise marginally stable structures to resist aggregation under conditions in which they exert their biological function. 24 
Relationship to Other Protein Aggregation Diseases
Generic Aspects of Amyloid Formation and Disease. A chance observation, made just as we had started to explore the mechanism of lysozyme fibril formation, suggested that perfectly ordinary proteins, unrelated to any known disease, can form amyloid fibrils with all the characteristics of those found in lysozyme amyloidosis, or indeed in the 20 or so other related misfolding conditions including Alzheimer's disease and type II diabetes. 25 This finding, which was closely followed by an independent report of a similar observation, 26 stimulated us to begin a series of investigations of the abilities of a range of peptides and proteins to form amyloid fibrils, of the mechanisms by which they do so, and of the properties of the aggregates. These studies led us to the conclusion that many, perhaps in principle nearly all, proteins have the intrinsic ability to convert into amyloid or amyloidlike fibrils in vitro if appropriate conditions can be found. 24, 27 Further studies also led to the suggestion that there are likely to be many common structural and mechanistic features underlying protein misfolding and aggregation. 27 This conclusion is consistent with the fact that the fibrillar aggregates associated with all the known amyloid-related diseases appear similar in their overall character and morphology despite little, if any, similarities in the sequences or native structures of the peptides or proteins (whether intact or fragmented) that represent the major components of the pathological deposits. 27 On the basis of this and other such evidence, we believe that the formation of amyloid fibrils is a consequence of the inherent physicochemical properties of polypeptide chains and that amyloid disorders result fundamentally from the reversion of a peptide or protein in its native state to this alternative and generic form of polypeptide structure. 24, 27, 28 In general, as in the case of lysozyme, the structure of at least some, and perhaps the majority, of regions of a protein in its fibrillar form will differ substantially from that of the protein in its functional state, whether the latter is globular or natively unfolded. In the case of polypeptides that normally fold to globular structures, specific packing between the side chains and exclusion of many of the hydrophobic groups from water stabilize states in which the main chain is folded into unique and often highly intricate native structures in which the surface regions are designed to avoid inappropriate intermolecular interactions. 29 In these structures, intramolecular hydrogen bonds are formed between the main-chain amide and carbonyl groups in the familiar R-helices, -sheets, loops, and turns. 29 The overall architecture of a given fold and its net stability relative to that of other globular folds, the denatured state, or indeed the amyloid structure, depend on the specific nature of the side-chain interactions within that fold and so is encoded in the sequence of the protein. Native proteins, even under physiological conditions, are at best only marginally stable relative to these alternatives states. 29 While globular proteins in their native states are usually highly resistant to aggregation because of their closepacked structures, when such a protein is even partially or transiently unfolded, its propensity to aggregate can be dramatically enhanced. In vitro aggregation, including formation of amyloid fibrils, is therefore often associated with the disruption of the native structure of a protein provided the latter occurs under conditions in which relatively stable noncovalent interactions, particularly hydrogen bonding, can still occur. 24 In vivo, despite the plethora of housekeeping mechanisms such as molecular chaperones and the unfolded protein response, there is a finite chance that any protein molecule produced in a cell may fail to fold correctly or to remain correctly folded and hence is prone to aggregate. 28 In the case of lysozyme, our knowledge of the effects of natural amyloidogenic mutations on the properties of the protein points to the conclusion that the formation of fibrils in vivo results from a series of factors that combine to generate pathogenic behavior. First, the amyloidogenic variants are able to fold sufficiently well to escape degradation by the cellular quality control systems and hence to be secreted in significant amounts into extracellular space where they normally function. Second, the mutations decrease the stability and global cooperativity of the protein sufficiently to enable the variants to unfold partially and populate intermediate states at a significant level. And third, the region of the polypeptide chain that is exposed as the result of this unfolding event is highly aggregation prone and hence can initiate the events that ultimately lead to the formation of amyloid fibrils. One can speculate from these findings that the relative rarity of amyloidoses is likely to reflect not just the efficiency of the biological mechanisms that defend against protein aggregation but also the importance of multiple risk factors of this type for a given protein.
New Paradigms of Protein Structure. Within the amyloid core structure, an array of inter-and intramolecular hydrogen bonds is formed between the main-chain amide and carbonyl groups that are common to all peptides and proteins (except where proline residues are present). Both solid-state NMR and X-ray studies suggest that the side chains of the component amino acid residues can possess a very high degree of order, akin to the situation when peptides and other molecules form threedimensional crystals. 30, 31 The interactions between side chains (and sometimes simply their burial from solvent Normal and Aberrant Biological Self-Assembly Dumoulin et al. water) will undoubtedly contribute to the stability of the amyloid structure and explains, at least in part, the fact that the propensity to convert to this state varies dramatically with the composition and sequence of any given polypeptide chain. 21 In addition, the repetitive nature and degree of order of the long-range interactions within the highly organized fibril core are important in stabilizing the amyloid state.
Fibrils formed from wild-type human lysozyme can seed the formation of fibrils from solutions of hen lysozyme, a protein with approximately 60% sequence identity. 32 The efficiency of seeding, however, is lower than that carried out with preformed fibrils from proteins having a higher sequence similarity to hen lysozyme including turkey lysozyme or a single-point mutational variant of hen lysozyme. 32 These results show clearly that the side chains of the residues involved in the core of the fibrils, and perhaps also those of the residues that make up the regions peripheral to the fibril core, influence the propensity to form the amyloid structure relative to the many alternative states accessible in principle to a polypeptide chain. Side-chain residues have also been shown to affect the specific details of the fibril structures, for example, the separation between -sheets and the manner in which protofilaments assemble to form fibrils. 33 However, by contrast to the situation for native states, where the specific interactions of particular side chains is essential to stabilize the overall fold, we believe that in the amyloid form of a peptide or protein, the side chains, whatever their nature, generally accommodate themselves as favorably as possible in a structure whose essential character is determined by common features of the polypeptide chain. 24 
Future Perspectives
The diseases associated with protein misfolding are rapidly emerging as among the most feared and debilitating in the modern world. We believe that the rapidly increasing prevalence of disorders such as Alzheimer's disease and type II diabetes results ultimately from the fact that our proteins and the environments in which they function have been selected by evolution to be resistant to aggregation only to the extent necessary for the competitive success of our species. 24, 27 Under other conditions, the most vulnerable of our proteins will progressively tend to revert to the generic amyloid structure. In today's society, we strive to go beyond our evolutionary fitness through, for example, extended life spans and radically altered lifestyles. 34 Nevertheless, we believe that studies of the type described here have begun to generate a sufficiently profound understanding of the distinctive differences between normal and aberrant folding behavior and, hence, identified a wide variety of novel strategies through which rational therapeutic intervention could lead to effective prevention or treatment of perhaps the entire family of protein misfolding disorders 28 [ Figure 6 ].
